VolitionRx
In Brief This Week: Oncotelic Therapeutics, VolitionRx, Genetron Health
News items for the week of Nov. 7, 2022.
VolitionRx, MD Anderson Cancer Center Partner to Study Cancer Patients With Sepsis
The study will use Volition's CE-marked Nu.Q NETs test to evaluate the role of neutrophil extracellular traps in cancer patients with sepsis.
VolitionRx Signs on Diagnostic Oncology CRO for Clinical Studies of Cancer, Sepsis Tests
DXOCRO will conduct large-scale clinical utility studies of Volition's Nu.Q NETs and Nu.Q Cancer tests at multiple sites in the US.